These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Characteristics and management of erectile dysfunction after various treatments for prostate cancer. Soh J; Kaiho Y; Kikuchi E; Oya M; Yoshioka K; Nakagami Y; Hatano T; Ozu C; Horiguchi Y; Namiki K; Tachibana M; Hisasue S; Tanaka N; Asakawa I Int J Urol; 2010 Aug; 17(8):689-97. PubMed ID: 20590940 [No Abstract] [Full Text] [Related]
7. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how? Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626 [TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer. Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922 [TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer Therapeutics and Their Complications: A Primer for the Primary Care Provider. Brownlee Z; De Souza A; Koffer PP; DiPetrillo TA; Mega AE R I Med J (2013); 2020 Apr; 103(3):41-45. PubMed ID: 32236161 [No Abstract] [Full Text] [Related]
10. High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial. Zapatero A; Guerrero A; Maldonado X; Alvarez A; Gonzalez San Segundo C; Cabeza Rodríguez MA; Macias V; Pedro Olive A; Casas F; Boladeras A; de Vidales CM; Vazquez de la Torre ML; Villà S; Perez de la Haza A; Calvo FA Lancet Oncol; 2015 Mar; 16(3):320-7. PubMed ID: 25702876 [TBL] [Abstract][Full Text] [Related]
11. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer. Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and Skeletal-related Events Following Localized Prostate Cancer Treatment: Role of Surgery, Radiotherapy, and Androgen Deprivation. Wallis CJ; Mahar AL; Satkunasivam R; Herschorn S; Kodama RT; Lee Y; Kulkarni GS; Narod SA; Nam RK Urology; 2016 Nov; 97():145-152. PubMed ID: 27502032 [TBL] [Abstract][Full Text] [Related]
13. [Optimizing local control of high-risk prostate cancers through multimodal treatments]. Latorzeff I Prog Urol; 2019 Jun; 29 Suppl 1():S8-S19. PubMed ID: 31307631 [TBL] [Abstract][Full Text] [Related]
14. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow. Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849 [TBL] [Abstract][Full Text] [Related]
15. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865 [TBL] [Abstract][Full Text] [Related]
16. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555 [TBL] [Abstract][Full Text] [Related]
17. [Combined radiation therapy and androgen deprivation in the management of prostate cancer: Where do we stand?]. Bellefqih S; Hadadi K; Mezouri I; Maghous A; Marnouche E; Andaloussi K; Elmarjany M; Sifat H; Mansouri H; Benjaafar N Cancer Radiother; 2016 Apr; 20(2):141-50. PubMed ID: 26969245 [TBL] [Abstract][Full Text] [Related]
18. [Prostate cancer external beam radiotherapy]. de Crevoisier R; Pommier P; Latorzeff I; Chapet O; Chauvet B; Hennequin C Cancer Radiother; 2016 Sep; 20 Suppl():S200-9. PubMed ID: 27516051 [TBL] [Abstract][Full Text] [Related]
19. Re: The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Taneja SS J Urol; 2013 Nov; 190(5):1763-4. PubMed ID: 24120777 [No Abstract] [Full Text] [Related]
20. Re: The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Griebling TL J Urol; 2014 Apr; 191(4):1056. PubMed ID: 24703136 [No Abstract] [Full Text] [Related] [Next] [New Search]